Cargando…

Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma

BACKGROUND: To explore spotted temporal lobe necrosis (TLN) and changes in brain magnetic resonance imaging (MRI) after image-guided radiotherapy (IGRT) in a patient with nasopharyngeal carcinoma (NPC). Case presentation: a 57-year-old male was diagnosed with stage III NPC, cT1N2M0, in 2017. He unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Yu-Wei, Liao, Li-Jen, Wu, Chia-Yun, Lo, Wu-Chia, Shueng, Pei-Wei, Hsu, Chen-Xiong, Guo, Deng-Yu, Hou, Pei-Yu, Hsieh, Pei-Ying, Hsieh, Chen-Hsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532156/
https://www.ncbi.nlm.nih.gov/pubmed/36204045
http://dx.doi.org/10.1155/2022/5877106
_version_ 1784802055084310528
author Chiang, Yu-Wei
Liao, Li-Jen
Wu, Chia-Yun
Lo, Wu-Chia
Shueng, Pei-Wei
Hsu, Chen-Xiong
Guo, Deng-Yu
Hou, Pei-Yu
Hsieh, Pei-Ying
Hsieh, Chen-Hsi
author_facet Chiang, Yu-Wei
Liao, Li-Jen
Wu, Chia-Yun
Lo, Wu-Chia
Shueng, Pei-Wei
Hsu, Chen-Xiong
Guo, Deng-Yu
Hou, Pei-Yu
Hsieh, Pei-Ying
Hsieh, Chen-Hsi
author_sort Chiang, Yu-Wei
collection PubMed
description BACKGROUND: To explore spotted temporal lobe necrosis (TLN) and changes in brain magnetic resonance imaging (MRI) after image-guided radiotherapy (IGRT) in a patient with nasopharyngeal carcinoma (NPC). Case presentation: a 57-year-old male was diagnosed with stage III NPC, cT1N2M0, in 2017. He underwent concurrent chemoradiation therapy (CCRT) with cisplatin (30 mg/m(2)) and 5- fluorouracil (5-FU, 500 mg/m(2)) plus IGRT with 70 Gy in 35 fractions for 7 weeks. The following MRI showed a complete response in the NPC. However, the patient suffered from fainting periodically when standing up approximately 3 years after CCRT. Neck sonography showed mild atherosclerosis (< 15%) of bilateral carotid bifurcations and bilateral small-diameter vertebral arteries, with reduced flow volume. The following MRI showed a 9 mm × 7 mm enhancing lesion in the right temporal lobe without locoregional recurrence, and TLN was diagnosed. The lesion was near the watershed area between the anterior temporal and temporo-occipital arteries. The volume of the necrotic lesion was 0.51 c.c., and the mean dose and Dmax of the lesion were 64.4 Gy and 73.7 Gy, respectively. Additionally, the mean dose, V45, D1 c.c. (dose to 1 ml of the temporal lobe volume), D0.5 c.c. and Dmax of the right and left temporal lobes were 11.1 Gy and 11.4 Gy, 8.5 c.c. and 6.7 c.c., 70.1 Gy and 67.1 Gy, 72.0 Gy and 68.8 Gy, and 74.2 Gy and 72.1 Gy, respectively. CONCLUSION: Spotted TLN in patients with NPC treated by IGRT may be difficult to diagnose due to a lack of clinical symptoms and radiological signs. Endothelial damage may occur in carotid and vertebral arteries within the irradiated area, affecting the small branches supplying the temporal lobe and inducing spotted TLN. Future research on the relationship between vessels and RT or CCRT and the development of TLN is warranted.
format Online
Article
Text
id pubmed-9532156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95321562022-10-05 Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma Chiang, Yu-Wei Liao, Li-Jen Wu, Chia-Yun Lo, Wu-Chia Shueng, Pei-Wei Hsu, Chen-Xiong Guo, Deng-Yu Hou, Pei-Yu Hsieh, Pei-Ying Hsieh, Chen-Hsi Case Rep Otolaryngol Case Report BACKGROUND: To explore spotted temporal lobe necrosis (TLN) and changes in brain magnetic resonance imaging (MRI) after image-guided radiotherapy (IGRT) in a patient with nasopharyngeal carcinoma (NPC). Case presentation: a 57-year-old male was diagnosed with stage III NPC, cT1N2M0, in 2017. He underwent concurrent chemoradiation therapy (CCRT) with cisplatin (30 mg/m(2)) and 5- fluorouracil (5-FU, 500 mg/m(2)) plus IGRT with 70 Gy in 35 fractions for 7 weeks. The following MRI showed a complete response in the NPC. However, the patient suffered from fainting periodically when standing up approximately 3 years after CCRT. Neck sonography showed mild atherosclerosis (< 15%) of bilateral carotid bifurcations and bilateral small-diameter vertebral arteries, with reduced flow volume. The following MRI showed a 9 mm × 7 mm enhancing lesion in the right temporal lobe without locoregional recurrence, and TLN was diagnosed. The lesion was near the watershed area between the anterior temporal and temporo-occipital arteries. The volume of the necrotic lesion was 0.51 c.c., and the mean dose and Dmax of the lesion were 64.4 Gy and 73.7 Gy, respectively. Additionally, the mean dose, V45, D1 c.c. (dose to 1 ml of the temporal lobe volume), D0.5 c.c. and Dmax of the right and left temporal lobes were 11.1 Gy and 11.4 Gy, 8.5 c.c. and 6.7 c.c., 70.1 Gy and 67.1 Gy, 72.0 Gy and 68.8 Gy, and 74.2 Gy and 72.1 Gy, respectively. CONCLUSION: Spotted TLN in patients with NPC treated by IGRT may be difficult to diagnose due to a lack of clinical symptoms and radiological signs. Endothelial damage may occur in carotid and vertebral arteries within the irradiated area, affecting the small branches supplying the temporal lobe and inducing spotted TLN. Future research on the relationship between vessels and RT or CCRT and the development of TLN is warranted. Hindawi 2022-09-27 /pmc/articles/PMC9532156/ /pubmed/36204045 http://dx.doi.org/10.1155/2022/5877106 Text en Copyright © 2022 Yu-Wei Chiang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Chiang, Yu-Wei
Liao, Li-Jen
Wu, Chia-Yun
Lo, Wu-Chia
Shueng, Pei-Wei
Hsu, Chen-Xiong
Guo, Deng-Yu
Hou, Pei-Yu
Hsieh, Pei-Ying
Hsieh, Chen-Hsi
Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
title Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
title_full Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
title_fullStr Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
title_full_unstemmed Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
title_short Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
title_sort spotted temporal lobe necrosis following concurrent chemoradiation therapy using image-guided radiotherapy for nasopharyngeal carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532156/
https://www.ncbi.nlm.nih.gov/pubmed/36204045
http://dx.doi.org/10.1155/2022/5877106
work_keys_str_mv AT chiangyuwei spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT liaolijen spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT wuchiayun spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT lowuchia spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT shuengpeiwei spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT hsuchenxiong spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT guodengyu spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT houpeiyu spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT hsiehpeiying spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma
AT hsiehchenhsi spottedtemporallobenecrosisfollowingconcurrentchemoradiationtherapyusingimageguidedradiotherapyfornasopharyngealcarcinoma